Influence of Darolutamide on Cabazitaxel Systemic Exposure

Autor: Stefan A J, Buck, Niels A D, Guchelaar, Peter, de Bruijn, Inge M, Ghobadi Moghaddam-Helmantel, Esther, Oomen-de Hoop, Hans M, Westgeest, Paul, Hamberg, Danielle, Mathijssen-van Stein, Martijn P, Lolkema, Stijn L W, Koolen, Ronald, de Wit, Ron H J, Mathijssen

Publikováno v: Clinical pharmacokinetics. 61(10)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0c8fc4969278af0e77af74c583c16c73
https://pubmed.ncbi.nlm.nih.gov/35895277

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era

Autor: Gerrit Jan Veldhuis, Edith B. van Druten, Cathrien S. Tromp-van Driel, Ronald C. Rietbroek, Gerty J. de Klerk, Annebeth W. Haringhuizen, Theo van Voorthuizen, J. E. Vincent, Manuel L. R. Tjin-A-Ton, Anne M. May, Ankie M.T. van der Velden, Geraldine R. Vink, Brigitte C. M. Haberkorn, J. Cornelis B. Hunting, Joyce M. van Dodewaard-de Jong, R. Hoekstra, Lieke H.J. Simkens, Sandra D. Bakker, Patricia Quarles van Ufford-Mannesse, Jeanine M.L. Roodhart, Geert-Jan Creemers, Marjan A. van Dijk, Marco B. Polee, G. Emerens Wensink, Cornelis J. A. Punt, Daan ten Bokkel Huinink, Marloes A. G. Elferink, Bea Tanis, Franchette W P J van den Berkmortel, Henk M.W. Verheul, Danielle Mathijssen-van Stein, Miriam Koopman, Hanneke J. H. M. J. Vestjens, Sandra A Radema, J.F.M. Pruijt, Monique M. Troost, Onno Kranenburg, Jan Willem B. de Groot, Anke J. M. van der Pas, Agnes J. van de Wouw, Emile D. Kerver, Patricia A. H. Hamers, Linda Mol

Publikováno v: British Journal of Cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 124, 399-406
British journal of cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer, 124, 2, pp. 399-406
Wensink, G E, Elferink, M A G, May, A M, Mol, L, Hamers, P A H, Bakker, S D, Creemers, G-J, de Groot, J W B, de Klerk, G J, Haberkorn, B C M, Haringhuizen, A W, Hoekstra, R, Hunting, J C B, Kerver, E D, Mathijssen-van Stein, D, Polée, M B, Pruijt, J F M, Quarles van Ufford-Mannesse, P, Radema, S, Rietbroek, R C, Simkens, L H J, Tanis, B C, ten Bokkel Huinink, D, Tjin-A-Ton, M L R, Tromp-van Driel, C S, Troost, M M, van de Wouw, A J, van den Berkmortel, F W P J, van der Pas, A J M, van der Velden, A M T, van Dijk, M A, van Dodewaard-de Jong, J M, van Druten, E B, van Voorthuizen, T, Jan Veldhuis, G, Verheul, H M W, Vestjens, H J H M J, Vincent, J, Kranenburg, O W, Punt, C J A, Vink, G R, Roodhart, J M L & Koopman, M 2021, ' Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era ', British Journal of Cancer, vol. 124, no. 2, pp. 399-406 . https://doi.org/10.1038/s41416-020-01076-0

BackgroundMetastatic colorectal cancer patients with deficient mismatch repair (dMMR mCRC) benefit from immunotherapy. Interpretation of the single-arm immunotherapy trials is complicated by insignificant survival data during systemic non-immunothera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0117d001dca85f91775734a7c4208f2d
https://research.vumc.nl/en/publications/4d0a604d-b0c0-44c7-b106-5b8d5ff6f3c4